Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
JLARC adopts comments urging transparency and broader sunset review on drug take‑back fee design
Summary
JLARC adopted committee comments endorsing a recommendation that the Department of Health publicly report oversight costs and urged the upcoming 2026 sunset review to recommend best practices before the legislature considers removing the fee cap.
The Joint Legislative Audit and Review Committee unanimously adopted a proposed committee comment April 8 urging the Department of Health (DOH) to make its oversight costs for the drug take‑back program publicly available and recommending that any legislative changes to fee design wait for JLARC's 2026 sunset review.
JLARC staff presented an expedited review of the drug take‑back program fee setting and expenditures that concluded the statutory fee cap, which ties allowable DOH oversight fees to program operator spending, limits…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
